<DOC>
	<DOCNO>NCT01614912</DOCNO>
	<brief_summary>The study evaluate long term safety efficacy SM-13496 patient schizophrenia .</brief_summary>
	<brief_title>Long-term Extension Study SM-13496 ( Lurasidone HCl ) Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>Patients consider investigator eligible present study significant safety concern Patients fully inform understand objective , procedure , possible benefit risk study provide write voluntarily consent participate study Patients plan pregnancy expect duration study Patients otherwise consider ineligible study investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>